ZDTIs
ZDTIs, or Zinc Finger DNA Transcription Inhibitors, are a class of drugs that inhibit the activity of transcription factors, which are proteins that regulate gene expression. These inhibitors are designed to bind to the DNA-binding domain of transcription factors, preventing them from activating or repressing gene transcription. ZDTIs are being explored for their potential therapeutic applications in various diseases, including cancer and inflammatory disorders.
The development of ZDTIs has been driven by the need for more specific and targeted therapies. Unlike
One of the key advantages of ZDTIs is their potential to modulate gene expression in a reversible
However, the development of ZDTIs also faces challenges. One of the main issues is the specificity of
In summary, ZDTIs represent a promising class of drugs with the potential to revolutionize the treatment of